Please Scroll Down to See Forums Below 
THE RECOMPOSITION ARCHETYPE: PHYSIQUE & PERFORMANCE LOG
LOG ENTRY DATE: May 9, 2026
CURRENT AGE: 56 Years Old
TRAINING EXPERIENCE: 15 Months (Consistent Progressive Hypertrophy)
GOAL: Golden Era Aesthetic Evolution (V-Taper Focus & Pure Lean Mass Accretion)
HISTORIC TRANSFORMATION & DOSAGE EVOLUTION
Phase 1: Initiation, Heavy Weight Reduction & Metabolic Reset
October 2024 Baseline: 279.0 lbs
(Peak weight, high visceral fat accumulation).
April 2025: Initiated TRT at 140mg Testosterone weekly to correct baseline clinical deficiencies and establish a hormonal foundation.
July 2025: Titrated Testosterone upward to 180mg weekly to match increasing physical demands and lean mass potential.
July 2025 Milestone: Scaled down to 185.0 lbs (Total Net Weight Loss: -94.0 lbs).
July 2025 – February 2026: Held flat at 185.0 lbs for 8 full months at strict maintenance. Successfully repaired baseline metabolism, optimized thyroid kinetics, reset BMR to 1,869 kcal, and locked HbA1c at 4.9%.
Phase 2: TRT+ Blast Configuration & Lean Mass Expansion
February 2026: Advanced to TRT+ protocol. Elevated Testosterone to 200mg weekly and introduced Nandrolone Decanoate (Deca) at 100mg weekly for targeted joint longevity and tissue fullness.
Weight initiated a clean upward trend from the 185.0 lbs set-point.
Mid-April 2026: Titrated Testosterone upward to 300mg weekly to maximize lean protein synthesis and compensate for high metabolic output.
May 1, 2026 (Current Step-Up): Bumped Nandrolone Decanoate to 150mg weekly.
Current Progress State (May 9, 2026): 197.0 lbs (+12.0 lbs net mass gain over 2 months since leaving maintenance).
Visual Check: Absolutely zero fat spillover. Pants waistline has gotten looser over the past 30 days, verifying that visceral organ fat is continually dropping via Zepbound while high free androgens drive muscle tissue hypertrophy.
CURRENT BIOMETRIC BASELINE
Total Body Weight: 197.0 lbs
Height: 6'0"
Subcutaneous Body Fat: 13.6% (Low Status) [subcutaneous fat tile]
Visceral Fat Index: 6 (Low Status — Flat Abdominal Wall, No Deep Organ Bloat) [visceral fat tile]
Calculated Lean Body Mass (LBM): ~166.3 lbs
Skeletal Muscle Mass: 105.2 lbs [skeletal muscle mass tile]
Skeletal Bone Mass: 24.1 lbs [skeletal mass tile]
Basal Metabolic Rate (BMR): 1,869 kcal (High Category) [bmr tile]
Metabolic Age: 42 Years Old (14 years younger than chronological age) [metabolic age tile]
Biological Age Evaluation: 27 Years Old (Top 10% of Global Health Cohort) [biological age tile]
Hume Health Score: 819 / 1000 (Very High Summary) [health score tile]
CLINICAL BIOMARKER PROFILE
BiomarkerCurrent LevelReference Status / Clinical Notes
Total Testosterone (MS)1,891 H ng/dLElevated / Optimal exogenous therapeutic saturation point [total testosterone tile]
Free Testosterone (Calc)429.6 H pg/mLElevated / High circulating unbound tissue-repair signaling [free testosterone tile]
SHBG36 nmol/LSolid Mid-Range / Perfect transport capacity balance [shbg tile]
Estradiol (E2)46 H pg/mLHigh-Normal / Optimal proportional balance for joint/bone health [estradiol tile]
Total Estrogens (IA)109 pg/mLNormal / Collective pool well-managed under current AI split [total estrogens tile]
Prolactin5.5 ng/mLNormal / Excellent baseline control; completely clear of 19-nor side effects [prolactin tile]
Hemoglobin A1c (HbA1c)4.9 %Elite Range / Premium insulin sensitivity & nutrient partitioning [hba1c tile]
Fasting Glucose91 mg/dLNormal / Completely stable carbohydrate metabolism [glucose tile]
Hematocrit50.0 %Normal / Safe blood viscosity threshold monitored closely [hematocrit tile]
Hemoglobin16.7 g/dLNormal / Strong oxygen-carrying capacity [hemoglobin tile]
Red Blood Cell Count5.71 10*6/uLNormal / Stable erythropoiesis [rbc tile]
ALT / AST17 / 17 U/LOutstanding / Near-zero hepatic or muscle-tissue cellular stress [alt tile, ast tile]
eGFR / Creatinine103 / 0.81 mg/dLExcellent / Highly functioning kidney filtration rates [egfr tile, creatinine tile]
Homocysteine10.0 umol/LNormal / Low systemic cardiovascular inflammatory markers [homocysteine tile]
Total Cortisol11.8 mcg/dLNormal / Stable adrenal response to continuous training [cortisol tile]
Blood Pressure117/72 mmHgNormal / Healthy vascular elasticity; no fluid volume strain [blood pressure tile]
Resting Heart Rate54 bpm (Low)Standard / Excellent aerobic foundation and low sleep stress [heart rate tile]
Heart Rate Variability68.3 msHigh / Superior parasympathetic nervous system recovery status [hrv tile]
Total T4 / Free T4 Index4.7 L / 1.5Low Total / Normal Index. Expected AAS protein carrier shift [total t4 tile, free t4 index tile]
Vitamin D (25-OH)78.4 ng/mLOptimal / Exceptional ceiling for bone density and hormone balance [vitamin d tile]
PSA Total2.180 ng/mLNormal / Safe prostate profile under current androgen load [psa tile]
CURRENT PHARMACOLOGICAL SCHEDULE
1. Androgen & Peptide Core (TRT+ Current Protocol)
Testosterone Cypionate: 300mg weekly.
Nandrolone Decanoate (Deca): 150mg
weekly (Current protocol step-up from May 1) [nandrolone label image].
Peptide Therapy: CJC-1295 (No DAC) / Ipamorelin. Dosed at 250 mcg each on a 5-days-on, 2-days-off (5/2) cycle.
Injection Frequency: Three Times Weekly (Tuesday / Thursday / Saturday).
Volumetric Execution Method: Single 1 mL syringe. Draw Testosterone Cypionate to the 0.50 mL mark, switch vials, and draw Nandrolone Decanoate until total volume hits the 0.75 mL mark.
Injection Site Rotation Matrix: 4-Way IM Rotation Loop: Right Ventrogluteal
Right Dorsogluteal Left Dorsogluteal Left Ventrogluteal.
2. Ancillary & Estrogen Management
Anastrozole (Arimidex): 1.25mg total weekly load. Split precisely to match injection pulses: 0.50mg Tuesday / 0.25mg Thursday / 0.50mg Saturday to maintain exact 46 pg/mL E2 homeostatic balance.
Zepbound (Tirzepatide): 7.5mg weekly injection. Administered Tuesday night. Drives peak delayed gastric emptying and maximum metabolic control through the mid-week training block (Wednesday/Thursday).
DAILY SUPPLEMENT PROTOCOL
Morning Stack (With Food): Animal Omega Pack (Provides 7g uncounted essential fatty acids + 60 calories for optimal cardiac lipid/HDL buffering),
NAC,
Milk
Thistle,
Vitamin D3 + K2.
Night Stack (Before Bed): P-5-P (50mg), ZMA Tech, KSM-66 Ashwagandha.
Daytime Split: P-5-P (50mg taken in the morning to maintain 100mg split daily saturation for absolute Prolactin suppression).
NUTRITION & CALORIC TARGETS
Net Daily Average Intake: 3,173 kcal (Calculated 250–300 calorie clean surplus over healed BMR line) [net calories tile].
Macro Target Split Averages: Protein: 240g (1.2g/lb body weight) | Carbohydrates: 331g | Fat: 101g (True value reflecting raw logged macros plus uncounted Animal Omega pack) [macros tile].
Pre-Workout Nutrient Window (90 Mins Prior): Oatmeal, 1 Whole Banana, 1 Scoop Whey Protein Isolate, 1 Serving Karbolyn Powder.
Intra-Workout Performance Solution: Essential Amino Acids (EAAs) blended with 10g Creatine Monohydrate suspended in 24–32 oz of fluid. Driven by high insulin sensitivity (4.9% A1c) directly into targeted muscle tissue.
TRAINING SCHEDULE (RP HYPERTROPHY APP)
Frequency: 5 Consecutive Days Weekly (Monday through Friday). Rest days locked to Saturday and Sunday to allow systemic nervous system decompression and weekend HRV spikes.
Training Philosophy: High Stimulus-to-Fatigue Ratio (SFR), strict progressive overload directed via Repetitions in Reserve (RIR).
Execution Cues: Low-to-Medium weights, high repetition ranges (12-18 reps), 3 to 4 total sets per movement. Deliberate 3-second eccentric (lowering) tempo with a dead-stop bottom stretch to eliminate momentum, spare connective tissue, and maximize localized muscle pumps safely.
TARGET MILESTONES FOR END OF JUNE
Composition Target: Lean Body Mass increase from 166.3 lbs to ~172.5–174.5 lbs (Projected net lean gain of 6–9 lbs via joint fluid volume expansion, glycogen storage, and true accelerated skeletal muscle
CRITICAL CRITERIA FOR THE 5-WEEK MID-JUNE CHECK-IN
To mathematically confirm that the 150mg step-up Deca dose is your permanent athletic "Sweet Spot," the next round of laboratory tests must meet the following safety boundaries:
Cardiovascular Stability: Blood pressure must hold near 117/72 with sleep resting heart rate remaining in the low 50s [blood pressure tile, heart rate tile]
Hormonal Control: Prolactin must verify at < 10.0 ng/mL, validating the 50mg/50mg P-5-P split [prolactin tile].
Lipid Protection: HDL must successfully resist 19-nor suppression and hold at or above 40.0 mg/dL, backed by the Animal Omega engine [hdl cholesterol tile].
Blood Thickness: Hematocrit must verify under 52.0% to avoid viscosity-induced cardiovascular strain [hematocrit tile].
Waist Preservation: The Hume Subcutaneous Fat tile must remain under 14.5% with looser fitting pants, confirming zero subcutaneous fluid spillover
LOG ENTRY DATE: May 9, 2026
CURRENT AGE: 56 Years Old
TRAINING EXPERIENCE: 15 Months (Consistent Progressive Hypertrophy)
GOAL: Golden Era Aesthetic Evolution (V-Taper Focus & Pure Lean Mass Accretion)
HISTORIC TRANSFORMATION & DOSAGE EVOLUTION
Phase 1: Initiation, Heavy Weight Reduction & Metabolic ResetOctober 2024 Baseline: 279.0 lbs
(Peak weight, high visceral fat accumulation).
April 2025: Initiated TRT at 140mg Testosterone weekly to correct baseline clinical deficiencies and establish a hormonal foundation.
July 2025: Titrated Testosterone upward to 180mg weekly to match increasing physical demands and lean mass potential.
July 2025 Milestone: Scaled down to 185.0 lbs (Total Net Weight Loss: -94.0 lbs).
July 2025 – February 2026: Held flat at 185.0 lbs for 8 full months at strict maintenance. Successfully repaired baseline metabolism, optimized thyroid kinetics, reset BMR to 1,869 kcal, and locked HbA1c at 4.9%.
Phase 2: TRT+ Blast Configuration & Lean Mass ExpansionFebruary 2026: Advanced to TRT+ protocol. Elevated Testosterone to 200mg weekly and introduced Nandrolone Decanoate (Deca) at 100mg weekly for targeted joint longevity and tissue fullness.
Weight initiated a clean upward trend from the 185.0 lbs set-point.
Mid-April 2026: Titrated Testosterone upward to 300mg weekly to maximize lean protein synthesis and compensate for high metabolic output.
May 1, 2026 (Current Step-Up): Bumped Nandrolone Decanoate to 150mg weekly.
Current Progress State (May 9, 2026): 197.0 lbs (+12.0 lbs net mass gain over 2 months since leaving maintenance).
Visual Check: Absolutely zero fat spillover. Pants waistline has gotten looser over the past 30 days, verifying that visceral organ fat is continually dropping via Zepbound while high free androgens drive muscle tissue hypertrophy.
CURRENT BIOMETRIC BASELINE
Total Body Weight: 197.0 lbs
Height: 6'0"
Subcutaneous Body Fat: 13.6% (Low Status) [subcutaneous fat tile]
Visceral Fat Index: 6 (Low Status — Flat Abdominal Wall, No Deep Organ Bloat) [visceral fat tile]
Calculated Lean Body Mass (LBM): ~166.3 lbs
Skeletal Muscle Mass: 105.2 lbs [skeletal muscle mass tile]
Skeletal Bone Mass: 24.1 lbs [skeletal mass tile]
Basal Metabolic Rate (BMR): 1,869 kcal (High Category) [bmr tile]
Metabolic Age: 42 Years Old (14 years younger than chronological age) [metabolic age tile]
Biological Age Evaluation: 27 Years Old (Top 10% of Global Health Cohort) [biological age tile]
Hume Health Score: 819 / 1000 (Very High Summary) [health score tile]
CLINICAL BIOMARKER PROFILEBiomarkerCurrent LevelReference Status / Clinical Notes
Total Testosterone (MS)1,891 H ng/dLElevated / Optimal exogenous therapeutic saturation point [total testosterone tile]
Free Testosterone (Calc)429.6 H pg/mLElevated / High circulating unbound tissue-repair signaling [free testosterone tile]
SHBG36 nmol/LSolid Mid-Range / Perfect transport capacity balance [shbg tile]
Estradiol (E2)46 H pg/mLHigh-Normal / Optimal proportional balance for joint/bone health [estradiol tile]
Total Estrogens (IA)109 pg/mLNormal / Collective pool well-managed under current AI split [total estrogens tile]
Prolactin5.5 ng/mLNormal / Excellent baseline control; completely clear of 19-nor side effects [prolactin tile]
Hemoglobin A1c (HbA1c)4.9 %Elite Range / Premium insulin sensitivity & nutrient partitioning [hba1c tile]
Fasting Glucose91 mg/dLNormal / Completely stable carbohydrate metabolism [glucose tile]
Hematocrit50.0 %Normal / Safe blood viscosity threshold monitored closely [hematocrit tile]
Hemoglobin16.7 g/dLNormal / Strong oxygen-carrying capacity [hemoglobin tile]
Red Blood Cell Count5.71 10*6/uLNormal / Stable erythropoiesis [rbc tile]
ALT / AST17 / 17 U/LOutstanding / Near-zero hepatic or muscle-tissue cellular stress [alt tile, ast tile]
eGFR / Creatinine103 / 0.81 mg/dLExcellent / Highly functioning kidney filtration rates [egfr tile, creatinine tile]
Homocysteine10.0 umol/LNormal / Low systemic cardiovascular inflammatory markers [homocysteine tile]
Total Cortisol11.8 mcg/dLNormal / Stable adrenal response to continuous training [cortisol tile]
Blood Pressure117/72 mmHgNormal / Healthy vascular elasticity; no fluid volume strain [blood pressure tile]
Resting Heart Rate54 bpm (Low)Standard / Excellent aerobic foundation and low sleep stress [heart rate tile]
Heart Rate Variability68.3 msHigh / Superior parasympathetic nervous system recovery status [hrv tile]
Total T4 / Free T4 Index4.7 L / 1.5Low Total / Normal Index. Expected AAS protein carrier shift [total t4 tile, free t4 index tile]
Vitamin D (25-OH)78.4 ng/mLOptimal / Exceptional ceiling for bone density and hormone balance [vitamin d tile]
PSA Total2.180 ng/mLNormal / Safe prostate profile under current androgen load [psa tile]
CURRENT PHARMACOLOGICAL SCHEDULE
1. Androgen & Peptide Core (TRT+ Current Protocol)
Testosterone Cypionate: 300mg weekly.
Nandrolone Decanoate (Deca): 150mg
weekly (Current protocol step-up from May 1) [nandrolone label image].
Peptide Therapy: CJC-1295 (No DAC) / Ipamorelin. Dosed at 250 mcg each on a 5-days-on, 2-days-off (5/2) cycle.
Injection Frequency: Three Times Weekly (Tuesday / Thursday / Saturday).
Volumetric Execution Method: Single 1 mL syringe. Draw Testosterone Cypionate to the 0.50 mL mark, switch vials, and draw Nandrolone Decanoate until total volume hits the 0.75 mL mark.
Injection Site Rotation Matrix: 4-Way IM Rotation Loop: Right Ventrogluteal
Right Dorsogluteal Left Dorsogluteal Left Ventrogluteal.2. Ancillary & Estrogen Management
Anastrozole (Arimidex): 1.25mg total weekly load. Split precisely to match injection pulses: 0.50mg Tuesday / 0.25mg Thursday / 0.50mg Saturday to maintain exact 46 pg/mL E2 homeostatic balance.
Zepbound (Tirzepatide): 7.5mg weekly injection. Administered Tuesday night. Drives peak delayed gastric emptying and maximum metabolic control through the mid-week training block (Wednesday/Thursday).
DAILY SUPPLEMENT PROTOCOLMorning Stack (With Food): Animal Omega Pack (Provides 7g uncounted essential fatty acids + 60 calories for optimal cardiac lipid/HDL buffering),
NAC,
Milk
Thistle,
Vitamin D3 + K2.
Night Stack (Before Bed): P-5-P (50mg), ZMA Tech, KSM-66 Ashwagandha.
Daytime Split: P-5-P (50mg taken in the morning to maintain 100mg split daily saturation for absolute Prolactin suppression).
NUTRITION & CALORIC TARGETSNet Daily Average Intake: 3,173 kcal (Calculated 250–300 calorie clean surplus over healed BMR line) [net calories tile].
Macro Target Split Averages: Protein: 240g (1.2g/lb body weight) | Carbohydrates: 331g | Fat: 101g (True value reflecting raw logged macros plus uncounted Animal Omega pack) [macros tile].
Pre-Workout Nutrient Window (90 Mins Prior): Oatmeal, 1 Whole Banana, 1 Scoop Whey Protein Isolate, 1 Serving Karbolyn Powder.
Intra-Workout Performance Solution: Essential Amino Acids (EAAs) blended with 10g Creatine Monohydrate suspended in 24–32 oz of fluid. Driven by high insulin sensitivity (4.9% A1c) directly into targeted muscle tissue.
TRAINING SCHEDULE (RP HYPERTROPHY APP)Frequency: 5 Consecutive Days Weekly (Monday through Friday). Rest days locked to Saturday and Sunday to allow systemic nervous system decompression and weekend HRV spikes.
Training Philosophy: High Stimulus-to-Fatigue Ratio (SFR), strict progressive overload directed via Repetitions in Reserve (RIR).
Execution Cues: Low-to-Medium weights, high repetition ranges (12-18 reps), 3 to 4 total sets per movement. Deliberate 3-second eccentric (lowering) tempo with a dead-stop bottom stretch to eliminate momentum, spare connective tissue, and maximize localized muscle pumps safely.
TARGET MILESTONES FOR END OF JUNE
Composition Target: Lean Body Mass increase from 166.3 lbs to ~172.5–174.5 lbs (Projected net lean gain of 6–9 lbs via joint fluid volume expansion, glycogen storage, and true accelerated skeletal muscle
CRITICAL CRITERIA FOR THE 5-WEEK MID-JUNE CHECK-INTo mathematically confirm that the 150mg step-up Deca dose is your permanent athletic "Sweet Spot," the next round of laboratory tests must meet the following safety boundaries:
Cardiovascular Stability: Blood pressure must hold near 117/72 with sleep resting heart rate remaining in the low 50s [blood pressure tile, heart rate tile]
Hormonal Control: Prolactin must verify at < 10.0 ng/mL, validating the 50mg/50mg P-5-P split [prolactin tile].
Lipid Protection: HDL must successfully resist 19-nor suppression and hold at or above 40.0 mg/dL, backed by the Animal Omega engine [hdl cholesterol tile].
Blood Thickness: Hematocrit must verify under 52.0% to avoid viscosity-induced cardiovascular strain [hematocrit tile].
Waist Preservation: The Hume Subcutaneous Fat tile must remain under 14.5% with looser fitting pants, confirming zero subcutaneous fluid spillover
